Clinical efficacy and safety of cervical intralymphatic immunotherapy for house dust mite allergic rhinitis: A pilot study

ConclusionsIn this first-in-human clinical study, cervical ILIT was demonstrated safe and induced allergen tolerance after 3 injections.

Source: American Journal of Otolaryngology - August 27, 2019 Category: Endocrinology Source Type: research